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INTRODUCTION:
The following case demonstrates the importance of including 
babesiosis, an under-recognized tick borne illness, in the differential 
diagnosis for summer fever in areas with a high prevalence of Ixodes 













A 43 year old male presented to the ER in July with eight days of 
fevers, chills, and congestion with a “sinus headaches”. He saw his 
family doctor who placed him on levofloxacin.  He took this for five 
days but continued to have persistent symptoms as well as higher 
temperatures with myalgias and arthralgias.  He had no rash. He 
saw his family physician who placed him on doxycycline of which he 
took one dose, however he began to feel worse, and presented to the 
emergency room.  He noted that he spends much of his time outdoors 
and had recently gone camping and hiking.  He denied any rashes.
PMHx: ADHD, migraine headaches, heart palpitations
PSH: Denies surgical history 
Fx: Denies history of infectious disease in the family
SHx: Works as electrical engineer, denies tobacco use, alcohol, or 
illicit drug use.  Denies recent travel
Allergies: Azithromycin (rash), penicillin (unknown reaction)
Medications: Tylenol PRN, doxycycline x 1 dose
ABSTRACT:
Introduction- Tick-borne illnesses, namely Lyme disease, are common in Eastern Pennsylvania. 
In the summertime, Lyme is frequently included in the differential for unexplained fever. While 
doxycycline is used to treat most tick-borne illnesses, it does not cover Babesia. As more cases of 
Babesiosis are being recognized, this diagnosis should be pondered in at risk individuals.  
Case presentation- A 41 year old gentleman presented to the ER with eight days of fevers, 
chills and congestion. He previously saw his family physician who placed him on levofloxacin. His 
fevers continued and developed myalgias and headaches. He returned to his doctor who changed 
his antibiotic to doxycycline. He took one dose of doxycycline without relief and came to the hospital. 
Initial labs revealed pancytopenia with transaminitis. Upon questioning, he stated that he had 
recently been hiking, but had not noticed any rash. He was admitted with a preliminary differential of 
Lyme disease versus Ehrlichiosis and was continued on doxycycline. Lyme and ehrlichia/anaplasma 
titers were sent. His fevers persisted and his hemoglobin decreased. Consequently, babesiosis was 
considered. A blood smear for parasites was sent which showed Babesia. Doxycycline was continued 
with the addition of atovaquone and azithromycin. His titers, excluding Babesia, were negative. His 
blood counts and LFTs improved and was discharged. 
Discussion- Babesiosis typically develops 1-6 weeks after tick bite. Symptoms include fevers, 
fatigue, as well as headaches and myalgias. Rash is typically absent unless co-infected with 
B.Burgdorferi. Mild disease is frequently self-limited leading to under diagnosis. Severe cases 
are usually seen in asplenic patients and hemolytic anemia, as well as transaminitis, may occur. 
Diagnosis is made through examination of the blood smear and first line treatment is with atovaqone 
and azithromycin. Given the prevalence of Ixodes ticks in Pennsylvania, when a patient presents with 
fevers in the summer, Babesiosis should be considered.
PHYSICAL EXAM:
Vital signs: T: 102.9, BP 151/83, HR:95,  RR:18, 
99% RA
General: Ill appearing
HEENT: PERLA, no scleral icterus, no sinus tenderness, 
no pharyngeal erythema or exudates. No enlarged tonsils 
Neck: Supple without thyromegally
CV: Mildly tachycardic, +S1/S2, no murmurs, rubs, 
gallops
Resp: Lungs CTA bilaterally
GI: Soft, NT/ND, +bowel sounds, no hepatosplenomegally
Extremities: No clubbing, cyanosis, or edema
Lymph: No lymphadenopathy
Neurologic: No focal deficits 
Skin: No rash present 
Musculoskeletal: No active synovitis 
Psychiatric: Mood appropriate
INVESTIGATIVE STUDIES: Tick Bourne 
Organisms
Lyme IgM: 1.01 (equivocal)
Lyme Total Ab: 0.71
Lyme Western Blot: One band  
Ehrlichia/Anaplasma serologies: Negative
B. Microti IgM: 1:64 (H)
B. Microti IgG: 1:64 (H)
Blood smear (malarial preparation): +Babesia 
(<0.1% parasitemia)
CONCLUSION (KEY POINTS):
In conclusion, it is important to consider babesiosis in a patient who presents with flu like symptoms 
in the summer months especially if the patient has known tick exposure. This is especially true in 
the Northeastern United States and Upper Midwest.  Furthermore, it is also important to realize that 
while most tick bourne illnesses are treated with doxycycline, appropriate treatment for babesiosis 
is atovaquone and azithromycin in mild disease and clindamycin and quinine in severe disease (or in 
patients with mild disease with allergies to traditional treatment).
DISCUSSION:
Babesiosis is caused by protozoa of the genus Babesia. These protozoa are mostly transmitted by 
tick vectors, though rarely may be transmitted through blood transfusions or through trans-placental 
transmission.  Transmission peaks during the warm months. These protozoa cause lysis of host 
red blood cells.  In the Northeastern United States (including Eastern Pennsylvania the location of 
this patient) B. microti is the most common etiologic agent and in fact this the most predominant 
species in the United States. Babesiosis is endemic in the Northeastern US, especially in New England 
(Nantucket, Martha’s Vineyard, Cape Cod), as well as in the upper Midwest.  Ixodes Scapularis (deer 
tick) is the main tick vector for not only B. microti but also Borrelia burgdorferi and Anaplasma 
phagocytophilum.  Co-infection is common in tick-infested areas. 
Clinically, patients may be asymptomatic, but if symptoms do occur patients will typically present 
with non-specific symptoms such as fatigue, malaise, weakness, and anorexia.  Other less common 
symptoms are also non-specific and include headache, sore throat, dyspnea, myalgias and 
arthralgias. Our patient had many of these symptoms. Fever usually occurs and may be very high.  
Splenomegally and hepatomegaly may be noted on exam.  Erythema migrans can be present if co-
infected with lyme.  The patient may also have signs of hemolytic anemia such as mild jaundice and 
dark urine.  Laboratory values usually show thrombocytopenia, anemia, and elevated liver enzymes.  
Leukocyte values may be variable.   Rarely, babesiosis may be severe and this usually depends on 
degree of parasitemia and immune status of the host.  Asplenic patients, older patients, and other 
immunocompromised states (HIV, cancer, transplant patients, patients on biologics) increase risk for 
severe illness.  In severe illness, multi-organ failure may occur.  
Definitive diagnosis is made by examining at the thin blood smear in which intracellular protozoa 
are present. The “Maltese cross” pattern may be present. Serology is non-diagnostic but can 
determine chronicity of disease.  Treatment should not be given for asymptomatic patients but 
may be considered if parasitemia is chronic.  Mild disease is typically treated with atovaquone and 
azithromycin.  In severe disease, typical treatment consists of clindamycin and quinine. Treatment is 
typically for 7-10 days.  In severe disease, exchange transfusion may be considered. It is important to 
note that babesiosis is not covered by doxycycline, which is commonly prescribed for other tick borne 
illnesses.  This is important as ticks may serve as vectors for multiple organisms and doxycycline may 
not be appropriate as sole empiric therapy.  
CLINICAL COURSE:
The patient was admitted to the hospital. He was given IVF 
and started on empiric doxycycline for questionable lyme 
disease vs. ehrlichiosis/anaplasmosis (given leukopenia) 
and respective serologies were sent.  He continued to have 
fevers and myalgias despite being on doxycycline.  He 
was seen by infectious disease who requested a blood 
smear for parasites and added babesia serologies. The 
blood smear was positive for babesia and the patient was 
started on azithromycin and atovaquone.  Doxycycline was 
initially continued as there was a concern for concomitant 
infection, but was discontinued once titers were negative. 
He had symptomatic and laboratory improvement and was 






Example of Maltese cross seen 
with babesiosis (1)
CDC
